ctrl K

CSPC Pharmaceutical Group... (CHJTF)

PNK: CHJTF · Real-Time Price · USD

0.64

0.00 (0.00%)

At close: Apr 30, 2025, 8:00 PM

CSPC Pharmaceutical Income Statement

Financials in HKD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	34.6B	35.98B	33.59B	28.03B	25.06B	18.47B	12.92B	11.08B
Cost of Revenue	10.2B	10.09B	8.11B	7.03B	7.02B	6.25B	5.11B	5.43B
Gross Profit	24.4B	25.88B	25.47B	21B	18.04B	12.22B	7.81B	5.65B
Operating Income	7.68B	7.89B	7.53B	6.11B	5.05B	4.05B	2.89B	2.39B
Interest Income	n/a	282.03M	220.84M	115.54M	73.41M	n/a	25.15M	13.01M
Pretax Income	8.23B	8.84B	8.23B	7.17B	5.18B	3.95B	2.9B	2.36B
Net Income	5.87B	6.09B	5.61B	5.16B	4.21B	3.21B	2.32B	1.88B
Selling & General & Admin	11.36B	13.35B	13.81B	11.64B	10.73B	7.12B	4.23B	2.99B
Research & Development	5.35B	4.64B	4.14B	3.25B	2.27B	1.39B	815.26M	403.14M
Other Expenses	n/a	814.85M	545.69M	n/a	n/a	181.19M	n/a	284.26M
Operating Expenses	16.72B	17.99B	17.95B	14.89B	13B	8.23B	4.9B	3.28B
Interest Expense	25.9M	28.95M	9.24M	13.75M	36.77M	76.9M	22.25M	37.35M
Selling & Marketing Expenses	10.06B	10.34B	10.44B	9.38B	n/a	6.44B	n/a	2.5B
Cost & Expenses	26.92B	28.08B	26.06B	21.92B	20.02B	14.48B	10.01B	8.7B
Income Tax Expense	1.45B	1.57B	1.4B	1.31B	1.01B	766.71M	572.6M	467.5M
Shares Outstanding (Basic)	11.87B	11.92B	11.95B	11.95B	11.95B	11.98B	11.7B	11.44B
Shares Outstanding (Diluted)	11.87B	11.92B	11.95B	11.96B	11.96B	11.98B	11.7B	11.53B
EPS (Basic)	0.49	0.59	0.57	0.49	0.35	0.27	0.20	0.16
EPS (Diluted)	0.49	0.59	0.57	0.49	0.35	0.27	0.20	0.16
EBITDA	8.53B	8.66B	9.28B	8.09B	5.35B	5.32B	4.19B	3.25B
EBIT	7.42B	7.61B	8.23B	7.18B	5.22B	4.5B	3.52B	2.92B
Depreciation & Amortization	1.12B	1.22B	1.04B	906.92M	784.21M	727.46M	699.04M	568.51M